Categories: News

Arena Solutions and MEDIcept Announce Partnership to Improve Compliance for Medical Device Manufacturers

FOSTER CITY, Calif., Dec. 3, 2020 /PRNewswire/ — Arena Solutions, the leading provider of cloud-based product development solutions for high tech, consumer electronics, and medical device industries, today announced a new partnership with MEDIcept, Inc., a leading international medical device and IVD compliance consulting firm.

This partnership combines Arena’s leading quality management system (QMS) solutions with complementary quality management, regulatory, and engineering support from MEDIcept. Arena QMS customers already accelerate software validation using Arena Validate. Now, these same companies can leverage a team with decades of medical device industry experience to assist with validation testing, collaborate on regulatory strategy and compliance, and address quality assurance requirements.

“Arena QMS and Validate have provided medical device customers with a better way to manage their product and quality processes while adhering to FDA, ISO, and EMA quality system regulations,” said Craig Livingston, CEO for Arena Solutions. “With MEDIcept’s proven team and consulting services, medical device companies can shorten the time required to get products to market and meet critical compliance mandates.”

“In business, it’s all about relationships. MEDIcept partners with companies like Arena Solutions to provide greater value to companies in the medical device and life sciences market,” said David Rothkopf, President at MEDIcept. “This new relationship with Arena will provide regulated companies with a trustworthy and streamlined quality management system. This will help pre-revenue companies rapidly develop products and quality systems, and more mature companies evolve by meeting their product and regulatory requirements with an easy-to-use QMS system.”

About Arena Solutions

Arena Solutions helps innovative electronic high tech and medical device companies create products that change the world. Arena unifies product lifecycle (PLM) and quality management (QMS) processes, allowing every participant throughout the product realization process from design to manufacturing to work together. With Arena, teams accelerate product development and delivery to increase profits. For more information, visit ArenaSolutions.com.

About MEDIcept

MEDIcept, Inc. is an international medical device and IVD compliance consulting firm. For over 20 years, we have assisted thousands of companies of all sizes with cost-effective Regulatory, Quality, and Clinical services. Our staff includes experienced FDA, ISO, and industry experts who work efficiently to develop and maintain compliance through Quality Systems, regulatory strategies, clinical trials, remediations and other services. MEDIcept will help navigate the complex FDA and international regulatory pathways, reduce business risk, and increase time-to-market while maximizing the potential for success.

Contacts:

Scott Reedy
Arena Solutions
media@arenasolutions.com
(866) 937-1438

Jason Gromek
MEDIcept, Inc.
jgromek@medicept.com  
(508) 494-9850

Related Files

signed authorization form arena.pdf

 

View original content:http://www.prnewswire.com/news-releases/arena-solutions-and-medicept-announce-partnership-to-improve-compliance-for-medical-device-manufacturers-301185412.html

SOURCE Arena Solutions

Staff

Recent Posts

The Power of Tracking: New Preliminary Data Underscores How MyFitnessPal Supports Weight Management Goals

Research highlights how nutrition tracking drives success for weight loss and health goals NEW YORK,…

1 hour ago

Vivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics Nationwide

Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to…

4 hours ago

Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B

– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing…

4 hours ago

Optinose Announces 1-for-15 Reverse Stock Split

YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company…

4 hours ago